BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 68 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,307,291 | -16.1% | 4,879,060 | -4.4% | 0.01% | -12.5% |
Q2 2023 | $83,777,031 | -9.5% | 5,102,132 | -7.9% | 0.01% | -20.0% |
Q1 2023 | $92,527,291 | +9.6% | 5,537,240 | +1.2% | 0.01% | 0.0% |
Q4 2022 | $84,398,646 | -6.7% | 5,469,775 | -9.7% | 0.01% | -16.7% |
Q3 2022 | $90,419,000 | -11.2% | 6,056,242 | -2.3% | 0.01% | -7.7% |
Q2 2022 | $101,869,000 | -23.2% | 6,200,205 | -6.2% | 0.01% | -27.8% |
Q1 2022 | $132,603,000 | -19.9% | 6,610,323 | +1.3% | 0.02% | -10.0% |
Q4 2021 | $165,528,000 | -3.7% | 6,527,110 | +2.5% | 0.02% | -13.0% |
Q3 2021 | $171,864,000 | -4.4% | 6,370,043 | +2.4% | 0.02% | -4.2% |
Q2 2021 | $179,850,000 | +18.1% | 6,218,886 | +7.4% | 0.02% | +9.1% |
Q1 2021 | $152,254,000 | -7.1% | 5,789,136 | +1.2% | 0.02% | -12.0% |
Q4 2020 | $163,854,000 | +36.5% | 5,719,149 | +13.6% | 0.02% | +8.7% |
Q3 2020 | $120,046,000 | +70.3% | 5,033,387 | +49.3% | 0.02% | +43.8% |
Q2 2020 | $70,487,000 | +112.6% | 3,370,972 | +82.0% | 0.02% | +77.8% |
Q1 2020 | $33,156,000 | – | 1,852,281 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |